This review details our current clinical and pre-clinical knowledge on TGFBR1*6A as a high frequency, low penetrance tumor susceptibility allele, and provides further rationale to assess its role as a modifier gene for breast cancer predisposition and tumor progression. This evidence concerns the gene TGFBR1 and breast carcinoma.